Technology’s Role In Advancing Outcomes & Reducing The Cost Of Care For The SMI Population is starting in

Blood Test Detects Alzheimer’s Damage Before Symptoms Appear

A simple blood test can reliably detect signs of the damage caused by Alzheimer’s disease before symptoms of confusion or memory loss are apparent. The test uses neurofilament light chain (NfL) levels in blood serum, which is elevated at the pre-symptomatic stages of familial Alzheimer’s disease. The blood test is not yet commercially available.

These findings were reported in “Serum Neurofilament Dynamics Predicts Neurodegeneration And Clinical Progression In Presymptomatic Alzheimer’s Disease” by Oliver Preische, Stephanie A. Schultz, and colleagues. The researchers analyzed data from the Dominantly Inherited Alzheimer Network and used ultrasensitive immunoassay technology to demonstrate . . .

Want To Read More? Log In Or Become A Paid Member
Resource Available For Paid OPEN MINDS Circle Members Only
Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!
If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.